TREM‐1 is a receptor constitutively expressed on neutrophils and monocyte subsets, linked to inflammatory response in infections or non‐infectious inflammatory pathologies, such as sepsis and rheumatoid arthritis [13, 14], and it can also be produced in its soluble form (sTREM‐1). Here, TREM1 is linked to rheumatoid arthritis.